BioCentury | Oct 17, 2020
Finance

Praxis sees strongest first-day among trio of IPOs as NASDAQ nears $16B raised in fresh paper

...TARGETSVEGF-A - Vascular endothelial growth factor AVEGF-C (VRP) - Vascular endothelial growth factor CVEGF-D - Vascular...
BioCentury | Oct 16, 2020
Product Development

Recent Phase III disappointment aside, the heart failure pipeline holds plenty to look forward to

...diuretics, antifibrotics,  direct cardiomyocyte modulators, immunotherapies and vascular...
...cardiac contractility and output while also decreasing vascular...
...macrophage state. Mesoblast says the cells also induce vascular...
BioCentury | Oct 9, 2020
Translation in Brief

Philogen immunocytokine for glioma; plus Nordic's radiotherapy, Beth Israel Deaconness, Molecular Partners and Alpine

...showed longitudinal gene expression changes in lung fluid and blood over 14 days, linked the vascular...
BioCentury | Sep 20, 2020
Product Development

Amgen highlights durability, seeks biomarkers as response rates slip for KRAS inhibitor AMG 510

...Programmed cell death 1 ligand 1VEGF – Vascular...
BioCentury | Sep 12, 2020
Politics, Policy & Law

NIH taking action on racial disparities in Alzheimer’s research

...Alzheimer’s research.Vanderbilt University in Nashville will study vascular...
BioCentury | Sep 5, 2020
Translation in Brief

Matt Disney’s microRNA-targeting angiogenesis compound; Arrakis’ platform to find compounds’ RNA targets; dual target CAR Ts for HIV and more

...9ARG2 – Arginase 2miR-377 – MicroRNA-377VEGF-A – Vascular...
...Therapeutics Inc. The Scripps Research Institute AstraZeneca plc Cancer Research UK Vascular...
BioCentury | Aug 29, 2020
Product Development

Next-wave Th1 cytokine cancer therapies aim for more precise targeting

...prone to safety issues because they promote vascular...
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...Sphingosine 1-phosphate receptor 1 TGFB1 – Transforming growth factor β 1TGFB3 – Transforming growth factor β 3VEGF – Vascular...
BioCentury | Aug 22, 2020
Management Tracks

Qiagen chairman steps down, plus changes at Sanifit and Xeris

...CBO of Brickell Biotech Inc. (NASDAQ:BBI). The Spanish biotech is developing a treatment for a rare vascular...
BioCentury | Aug 18, 2020
Product Development

Unity outlines path forward for anti-aging programs after Phase II osteoarthritis failure

...the ability to very accurately and sensitively assess disease progression using objective measures” such as vascular...
Items per page:
1 - 10 of 4490
BioCentury | Oct 17, 2020
Finance

Praxis sees strongest first-day among trio of IPOs as NASDAQ nears $16B raised in fresh paper

...TARGETSVEGF-A - Vascular endothelial growth factor AVEGF-C (VRP) - Vascular endothelial growth factor CVEGF-D - Vascular...
BioCentury | Oct 16, 2020
Product Development

Recent Phase III disappointment aside, the heart failure pipeline holds plenty to look forward to

...diuretics, antifibrotics,  direct cardiomyocyte modulators, immunotherapies and vascular...
...cardiac contractility and output while also decreasing vascular...
...macrophage state. Mesoblast says the cells also induce vascular...
BioCentury | Oct 9, 2020
Translation in Brief

Philogen immunocytokine for glioma; plus Nordic's radiotherapy, Beth Israel Deaconness, Molecular Partners and Alpine

...showed longitudinal gene expression changes in lung fluid and blood over 14 days, linked the vascular...
BioCentury | Sep 20, 2020
Product Development

Amgen highlights durability, seeks biomarkers as response rates slip for KRAS inhibitor AMG 510

...Programmed cell death 1 ligand 1VEGF – Vascular...
BioCentury | Sep 12, 2020
Politics, Policy & Law

NIH taking action on racial disparities in Alzheimer’s research

...Alzheimer’s research.Vanderbilt University in Nashville will study vascular...
BioCentury | Sep 5, 2020
Translation in Brief

Matt Disney’s microRNA-targeting angiogenesis compound; Arrakis’ platform to find compounds’ RNA targets; dual target CAR Ts for HIV and more

...9ARG2 – Arginase 2miR-377 – MicroRNA-377VEGF-A – Vascular...
...Therapeutics Inc. The Scripps Research Institute AstraZeneca plc Cancer Research UK Vascular...
BioCentury | Aug 29, 2020
Product Development

Next-wave Th1 cytokine cancer therapies aim for more precise targeting

...prone to safety issues because they promote vascular...
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...Sphingosine 1-phosphate receptor 1 TGFB1 – Transforming growth factor β 1TGFB3 – Transforming growth factor β 3VEGF – Vascular...
BioCentury | Aug 22, 2020
Management Tracks

Qiagen chairman steps down, plus changes at Sanifit and Xeris

...CBO of Brickell Biotech Inc. (NASDAQ:BBI). The Spanish biotech is developing a treatment for a rare vascular...
BioCentury | Aug 18, 2020
Product Development

Unity outlines path forward for anti-aging programs after Phase II osteoarthritis failure

...the ability to very accurately and sensitively assess disease progression using objective measures” such as vascular...
Items per page:
1 - 10 of 4490